CH563405A5
(es)
|
1971-09-10 |
1975-06-30 |
Duschinsky Robert Dr Schweiz I |
|
IL51342A
(en)
|
1977-01-27 |
1980-11-30 |
Abic Ltd |
Ethoxyquin derivatives,their preparation and pharmaceutical and veterinary compositions comprising them
|
US4230698A
(en)
|
1978-05-12 |
1980-10-28 |
Research Corporation |
2-Substituted arabinofuranosyl nucleosides and nucleotides
|
US4211773A
(en)
|
1978-10-02 |
1980-07-08 |
Sloan Kettering Institute For Cancer Research |
5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
|
AU5118979A
(en)
|
1978-10-16 |
1980-04-24 |
Takeda Chemical Industries Ltd. |
2,6-diaminoebularines
|
US4652554A
(en)
|
1982-02-22 |
1987-03-24 |
St. Jude Children's Research Hospital |
Nitro-substituted 1-β-D-arabinofuranosylcytosines
|
JPS60228497A
(ja)
|
1984-04-27 |
1985-11-13 |
Sumitomo Chem Co Ltd |
新規なアデニル酸誘導体
|
US4713383A
(en)
|
1984-10-01 |
1987-12-15 |
Ciba-Geigy Corporation |
Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
|
US4626526A
(en)
|
1984-10-26 |
1986-12-02 |
Warner-Lambert Company |
(S)-N6 -2-hydroxypropyladenosines
|
US4855304A
(en)
|
1985-01-10 |
1989-08-08 |
Repligen Corporation |
Dinucleoside pyrophosphates and pyrophosphate homologs as plant antivirals
|
JPS61219478A
(ja)
|
1985-03-26 |
1986-09-29 |
Potsupuribetsuto Fastener Kk |
溶接検知方法及び装置
|
PL144471B1
(en)
|
1985-04-22 |
1988-05-31 |
Polska Akad Nauk Centrum |
Method of obtaining novel 3',5'-cyclic adensine dithiophosphate
|
US4762823A
(en)
|
1985-10-16 |
1988-08-09 |
Sloan-Kettering Institute For Cancer Research |
Nucleosides of 5-monofluoromethyluracil and 5-difluoromethyluracil
|
US4797495A
(en)
|
1985-11-22 |
1989-01-10 |
Burroughs Wellcome Co. |
Benzo[c]carbazole propanediol compound and salts thereof
|
IL82206A0
(en)
|
1986-04-14 |
1987-10-30 |
Shell Int Research |
Halogenated heterocyclic ethers,their preparation and their use as herbicides
|
WO1988003147A1
(en)
|
1986-10-31 |
1988-05-05 |
Warner-Lambert Company |
Selected n6-substituted adenosines having selective a2 binding activity
|
SU1417408A1
(ru)
|
1986-12-02 |
1995-09-10 |
Г.П. Акулов |
Способ получения меченного тритием дезоксиаденозина
|
JPH0699467B2
(ja)
|
1987-03-04 |
1994-12-07 |
ヤマサ醤油株式会社 |
2▲’▼−デオキシ−2▲’▼(s)−アルキルピリミジンヌクレオシド誘導体
|
AU598946B2
(en)
|
1987-06-24 |
1990-07-05 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Nucleoside derivatives
|
DE3730542A1
(de)
|
1987-09-11 |
1989-04-06 |
Hoechst Ag |
Arzneimittel mit einem gehalt an bestimmten 6-mercaptopurin-derivaten, verwendung dieser 6-mercaptopurin-derivate, verfahren zur herstellung der arzneimittel sowie einige neue 6-mercaptopurin-derivate und verfahren zu deren herstellung
|
US4880784A
(en)
|
1987-12-21 |
1989-11-14 |
Brigham Young University |
Antiviral methods utilizing ribofuranosylthiazolo[4,5-d]pyrimdine derivatives
|
HU204843B
(en)
|
1988-09-27 |
1992-02-28 |
Merrell Dow Pharma |
Process for producing 2'-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
|
MX9203459A
(es)
|
1988-11-15 |
1992-08-01 |
Merrell Pharma Inc |
Nuevos derivados de 2'-halometilideno, 2'-etenilideno y 2'-etinilcitidina, uridina y guanosina.
|
US5616702A
(en)
|
1988-11-15 |
1997-04-01 |
Merrell Pharmaceuticals Inc. |
2-'-ethenylidene cytidine, uridine and guanosine derivatives
|
ZA898567B
(en)
|
1988-11-15 |
1990-08-29 |
Merrell Dow Pharma |
Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives
|
EP0371366A1
(en)
|
1988-11-21 |
1990-06-06 |
Syntex (U.S.A.) Inc. |
Antiviral agents
|
SE462497B
(sv)
|
1988-11-30 |
1990-07-02 |
Clas Fredrik Runesson Kaelland |
Saett foer att aktivitetsbestaemma polymeraser
|
FR2642074B1
(fr)
|
1989-01-20 |
1994-04-29 |
Oris Ind |
Derives de molecules polyhydroxylees permettant l'introduction d'au moins une ramification dans un oligonucleotide
|
US5296348A
(en)
|
1989-05-16 |
1994-03-22 |
The Wistar Institute Of Anatomy And Biology |
Methods for screening monoclonal antibodies for therapeutic use
|
DE3916871A1
(de)
|
1989-05-24 |
1990-11-29 |
Boehringer Mannheim Gmbh |
Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
|
DE3924424A1
(de)
|
1989-07-24 |
1991-01-31 |
Boehringer Mannheim Gmbh |
Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
|
JPH0699711B2
(ja)
|
1989-07-25 |
1994-12-07 |
花王株式会社 |
液体洗浄剤組成物
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
DE69034150T2
(de)
|
1989-10-24 |
2005-08-25 |
Isis Pharmaceuticals, Inc., Carlsbad |
2'-Modifizierte Oligonukleotide
|
US5514786A
(en)
|
1990-01-11 |
1996-05-07 |
Isis Pharmaceuticals, Inc. |
Compositions for inhibiting RNA activity
|
US5457191A
(en)
|
1990-01-11 |
1995-10-10 |
Isis Pharmaceuticals, Inc. |
3-deazapurines
|
US5578718A
(en)
|
1990-01-11 |
1996-11-26 |
Isis Pharmaceuticals, Inc. |
Thiol-derivatized nucleosides
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
US5852188A
(en)
|
1990-01-11 |
1998-12-22 |
Isis Pharmaceuticals, Inc. |
Oligonucleotides having chiral phosphorus linkages
|
AU651569B2
(en)
|
1990-01-11 |
1994-07-28 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for detecting and modulating RNA activity and gene expression
|
CA2037767A1
(en)
|
1990-03-23 |
1991-09-24 |
Mark D. Wittman |
Conversion of amines to hydroxylamines
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5478813A
(en)
|
1990-05-11 |
1995-12-26 |
Banyu Pharmaceutical Co., Ltd. |
Antitumor substance BE-13793C derivatives
|
AU7623991A
(en)
|
1990-05-17 |
1991-11-21 |
Syntex (U.S.A.) Inc. |
Antiviral agents
|
GB9012899D0
(en)
|
1990-06-09 |
1990-08-01 |
Wellcome Found |
Anti-hbv pyrimidine nucleoside
|
JP2559917B2
(ja)
|
1990-06-15 |
1996-12-04 |
三共株式会社 |
ピリミジンヌクレオシド誘導体
|
DE4019892A1
(de)
|
1990-06-22 |
1992-01-02 |
Boehringer Ingelheim Kg |
Neue xanthinderivate
|
MY106399A
(en)
|
1990-07-24 |
1995-05-30 |
Pfizer |
Cephalosporins and homologeus, preparation and pharmaceutical composition
|
US5138045A
(en)
|
1990-07-27 |
1992-08-11 |
Isis Pharmaceuticals |
Polyamine conjugated oligonucleotides
|
US5602240A
(en)
|
1990-07-27 |
1997-02-11 |
Ciba Geigy Ag. |
Backbone modified oligonucleotide analogs
|
US5378825A
(en)
|
1990-07-27 |
1995-01-03 |
Isis Pharmaceuticals, Inc. |
Backbone modified oligonucleotide analogs
|
IL99125A0
(en)
|
1990-08-10 |
1992-07-15 |
Gensia Pharma |
Derivatives of imidazole analog of aica riboside and their use
|
US5777100A
(en)
|
1990-08-10 |
1998-07-07 |
Gensia Inc. |
AICA riboside analogs
|
US6262241B1
(en)
|
1990-08-13 |
2001-07-17 |
Isis Pharmaceuticals, Inc. |
Compound for detecting and modulating RNA activity and gene expression
|
US5420115A
(en)
*
|
1990-09-10 |
1995-05-30 |
Burroughs Wellcome Co. |
Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
|
US5432272A
(en)
|
1990-10-09 |
1995-07-11 |
Benner; Steven A. |
Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
|
AU665184B2
(en)
|
1991-01-23 |
1995-12-21 |
Gensia, Inc. |
Adenosine kinase inhibitors
|
US5171849A
(en)
|
1991-04-19 |
1992-12-15 |
The Ohio State University Research Foundation |
2' and 3' Carboranyl uridines and their diethyl ether adducts
|
US5446031A
(en)
|
1991-04-24 |
1995-08-29 |
Yamasa Shuyu Kabushiki Kaisha |
1-β-D-arabinofuranosyl-(E)-5-(2-halogenovinyl)uracil derivatives
|
GB9111580D0
(en)
|
1991-05-30 |
1991-07-24 |
Wellcome Found |
Nucleoside derivative
|
US5192764A
(en)
|
1991-05-30 |
1993-03-09 |
Research Foundation Of State Of N.Y. |
Pyrazinone n-oxide nucleosides and analogs thereof
|
US5508407A
(en)
|
1991-07-10 |
1996-04-16 |
Eli Lilly And Company |
Retroviral protease inhibitors
|
JPH0551395A
(ja)
|
1991-08-21 |
1993-03-02 |
Teijin Ltd |
ペンタフルオロプロピオニル化(デオキシ)ウリジンおよびそれを用いる(デオキシ)ウリジンの測定方法
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
DE4131579A1
(de)
|
1991-09-23 |
1993-03-25 |
Boehringer Mannheim Gmbh |
Thiadiazolo(4,3-a)pyridinderivate, verfahren zu ihrer herstellung und diese enthaltenden arzneimittel
|
FI105556B
(fi)
|
1991-09-30 |
2000-09-15 |
Sankyo Co |
Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta
|
US6335434B1
(en)
|
1998-06-16 |
2002-01-01 |
Isis Pharmaceuticals, Inc., |
Nucleosidic and non-nucleosidic folate conjugates
|
AU3222793A
(en)
|
1991-11-26 |
1993-06-28 |
Gilead Sciences, Inc. |
Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
|
US6235887B1
(en)
|
1991-11-26 |
2001-05-22 |
Isis Pharmaceuticals, Inc. |
Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
|
IT1249732B
(it)
|
1991-11-26 |
1995-03-09 |
Angeletti P Ist Richerche Bio |
Oligonucleotidi antisenso.
|
FR2684997A1
(fr)
|
1991-12-12 |
1993-06-18 |
Centre Nat Rech Scient |
Derives de la 9-(beta-d-xylofurannosyl) adenine et de la 1-(beta-d-xylofurannosyl) cytosine, leur preparation et leur application en therapeutique.
|
FR2688003B1
(fr)
|
1992-02-28 |
1995-06-30 |
Univ Limoges |
Derives de nucleosides, leur preparation et leurs applications biologiques.
|
US5543507A
(en)
|
1992-03-05 |
1996-08-06 |
Isis Pharmaceuticals, Inc. |
Covalently cross-linked oligonucleotides
|
ATE170077T1
(de)
|
1992-04-10 |
1998-09-15 |
Merrell Pharma Inc |
Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
US5808139A
(en)
|
1992-04-21 |
1998-09-15 |
Ligand Pharmaceuticals Incorporated |
Non-steroid progesterone receptor agonist and antagonist and compounds and methods
|
ATE146183T1
(de)
|
1992-05-12 |
1996-12-15 |
Merrell Pharma Inc |
Verfahren zur herstellung von ribonukleotid- reduktasehemmern
|
US5625056A
(en)
|
1992-05-26 |
1997-04-29 |
Biolog Life Science Institute |
Derivatives of cyclic guanosine-3',5'-monophosphorothioate
|
DE4217679C2
(de)
|
1992-05-26 |
1998-02-19 |
Genieser Hans Gottfried Dr |
Cyclische Guanosin-3',5'-phosphorothioat-Derivate
|
CA2140428C
(en)
|
1992-07-23 |
2003-07-08 |
Daniel Peter Claude Mcgee |
Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
|
CA2159632A1
(en)
|
1993-03-31 |
1994-10-13 |
Ashis Kumar Saha |
Novel 5'-substituted nucleosides and oligomers produced therefrom
|
JP4086314B2
(ja)
|
1993-09-17 |
2008-05-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヌクレオチドアナログ
|
DE4341161A1
(de)
|
1993-12-02 |
1995-06-08 |
Michael Prof Dr Zeppezauer |
Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
JPH07242544A
(ja)
|
1994-03-01 |
1995-09-19 |
Takeda Chem Ind Ltd |
抗腫瘍剤
|
US5681940A
(en)
|
1994-11-02 |
1997-10-28 |
Icn Pharmaceuticals |
Sugar modified nucleosides and oligonucleotides
|
US6004939A
(en)
|
1995-07-06 |
1999-12-21 |
Ctrc Research Foundation Board Of Regents |
Methods for modulation and inhibition of telomerase
|
DE69712316T2
(de)
|
1996-01-23 |
2003-01-02 |
Icn Pharmaceuticals |
Modulation der th1/th2 cytokinexpression durch ribavirin in aktivierten t-lymphozyten
|
JPH09328497A
(ja)
|
1996-04-12 |
1997-12-22 |
Yamasa Shoyu Co Ltd |
4’−フルオロメチルヌクレオシド
|
KR100412480B1
(ko)
|
1996-10-16 |
2003-12-31 |
아이씨엔 파마슈티컬스, 인코포레이티드 |
푸린 l-누클레오시드, 이의 유사체 및 이들의 용도
|
ATE238328T1
(de)
|
1996-10-16 |
2003-05-15 |
Ribapharm Inc |
Monozyklische l-nukleoside, analoga und ihre anwendungen
|
US20030064945A1
(en)
|
1997-01-31 |
2003-04-03 |
Saghir Akhtar |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
JP4236812B2
(ja)
|
1997-09-12 |
2009-03-11 |
エクシコン エ/エス |
オリゴヌクレオチド類似体
|
US20030203862A1
(en)
|
1998-03-26 |
2003-10-30 |
Miraglia Loren J. |
Antisense modulation of MDM2 expression
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
AU4322799A
(en)
|
1998-05-28 |
1999-12-13 |
Incara Pharmaceuticals Corp. |
Carbohydrate-based scaffold compounds, combinatorial libraries and methods for their construction
|
DE19855963A1
(de)
|
1998-12-04 |
2000-06-08 |
Herbert Schott |
Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung
|
ATE465168T1
(de)
*
|
1999-03-18 |
2010-05-15 |
Exiqon As |
Xylo-lna analoge
|
AU776362B2
(en)
*
|
1999-05-04 |
2004-09-09 |
Roche Innovation Center Copenhagen A/S |
L-ribo-LNA analogues
|
JP4076114B2
(ja)
|
1999-05-12 |
2008-04-16 |
ヤマサ醤油株式会社 |
4’−c−エチニルプリンヌクレオシド化合物
|
BR0011521B8
(pt)
*
|
1999-05-12 |
2021-05-25 |
Yamasa Corp |
compostos nucleósidos de purina de 4 -c-etinila
|
PL354094A1
(en)
|
1999-08-27 |
2003-12-29 |
Icn Pharmaceuticals, Inc.Icn Pharmaceuticals, Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
US6831069B2
(en)
|
1999-08-27 |
2004-12-14 |
Ribapharm Inc. |
Pyrrolo[2,3-d]pyrimidine nucleoside analogs
|
IL133680A0
(en)
|
1999-09-10 |
2001-04-30 |
Can Fite Technologies Ltd |
Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist
|
CA2390821A1
(en)
|
1999-12-16 |
2001-06-21 |
Peter G. Klimko |
Inhibitors of adenosine kinase for the treatment of optic nerve and retinal damage
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
US6815542B2
(en)
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
UA72612C2
(en)
|
2000-07-06 |
2005-03-15 |
|
Pyrido[2.3-d]pyrimidine and pyrimido[4.5-d]pyrimidine nucleoside analogues, prodrugs and method for inhibiting growth of neoplastic cells
|
JP2002322192A
(ja)
*
|
2000-08-10 |
2002-11-08 |
Sankyo Co Ltd |
2’−o,4’−c−架橋ヌクレオシドトリリン酸体
|
WO2002031176A1
(fr)
|
2000-10-12 |
2002-04-18 |
Mitsui Chemicals, Inc. |
Procédé permettant la production de nucléosides
|
JP2004313002A
(ja)
|
2000-10-12 |
2004-11-11 |
Mitsui Chemicals Inc |
ヌクレオシドの製造方法
|
PT1411954E
(pt)
*
|
2000-10-18 |
2011-03-16 |
Pharmasset Inc |
Nucleosídeos modificados para o tratamento de infecções virais e proliferação celular anormal
|
ATE292973T1
(de)
|
2001-01-16 |
2005-04-15 |
Can Fite Biopharma Ltd |
Verwendung eines adenosin-a3-rezeptor-agonisten zur hemmung der virenreplikation
|
CN1267446C
(zh)
|
2001-01-22 |
2006-08-02 |
默克公司 |
作为依赖于rna的rna病毒聚合酶的抑制剂的核苷衍生物
|
JP2002302498A
(ja)
|
2001-04-03 |
2002-10-18 |
Mitsui Chemicals Inc |
ヌクレオシドの工業的な製造法
|
US20040204481A1
(en)
|
2001-04-12 |
2004-10-14 |
Pnina Fishman |
Activation of natural killer cells by adenosine A3 receptor agonists
|
WO2003070912A2
(en)
|
2001-06-06 |
2003-08-28 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
WO2002097114A2
(en)
|
2001-05-29 |
2002-12-05 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
|
US20030175950A1
(en)
|
2001-05-29 |
2003-09-18 |
Mcswiggen James A. |
RNA interference mediated inhibition of HIV gene expression using short interfering RNA
|
GB0114286D0
(en)
*
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
JP2003012690A
(ja)
|
2001-07-03 |
2003-01-15 |
Mitsui Chemicals Inc |
置換イミダゾール誘導体又は置換ベンズイミダゾール誘導体を用いたヌクレオチドの製造法
|
JP2003055392A
(ja)
|
2001-08-08 |
2003-02-26 |
Mitsui Chemicals Inc |
1−リン酸化糖の製造法並びにヌクレオシドの製造法
|
KR100894167B1
(ko)
*
|
2001-08-14 |
2009-04-22 |
토야마 케미칼 컴퍼니 리미티드 |
신규의 바이러스 증식저해 ·살바이러스방법 및 신규의피라진뉴클레오티드 ·피라진뉴클레오시드 유사체
|
US6962991B2
(en)
|
2001-09-12 |
2005-11-08 |
Epoch Biosciences, Inc. |
Process for the synthesis of pyrazolopyrimidines
|
WO2003026589A2
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
|
WO2003026675A1
(en)
|
2001-09-28 |
2003-04-03 |
Idenix (Cayman) Limited |
Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
|
US7037718B2
(en)
|
2001-10-26 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
|
AU2002351077A1
(en)
|
2001-11-05 |
2003-05-19 |
Exiqon A/S |
Oligonucleotides modified with novel alpha-l-rna analogues
|
US7125982B1
(en)
|
2001-12-05 |
2006-10-24 |
Frayne Consultants |
Microbial production of nuclease resistant DNA, RNA, and oligo mixtures
|
EP1572705A2
(en)
*
|
2002-01-17 |
2005-09-14 |
Ribapharm, Inc. |
Sugar modified nucleosides as viral replication inhibitors
|
WO2003062256A1
(en)
|
2002-01-17 |
2003-07-31 |
Ribapharm Inc. |
2'-beta-modified-6-substituted adenosine analogs and their use as antiviral agents
|
RU2004128943A
(ru)
|
2002-02-28 |
2005-04-20 |
Байота, Инк. (Us) |
Средства, имитирующие нуклеотиды, и их пролекарственные формы
|
EP1485396A2
(en)
|
2002-02-28 |
2004-12-15 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
TW200403058A
(en)
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
JP2003310293A
(ja)
|
2002-04-26 |
2003-11-05 |
Mitsui Chemicals Inc |
ヌクレオシド化合物の製造法
|
DK1501848T3
(da)
|
2002-05-08 |
2007-10-22 |
Santaris Pharma As |
Syntese af låst nukleinsyrederivater
|
US7569575B2
(en)
|
2002-05-08 |
2009-08-04 |
Santaris Pharma A/S |
Synthesis of locked nucleic acid derivatives
|
US20040014957A1
(en)
|
2002-05-24 |
2004-01-22 |
Anne Eldrup |
Oligonucleotides having modified nucleoside units
|
JP4902958B2
(ja)
|
2002-06-07 |
2012-03-21 |
ユニバーシテール・メディッシュ・セントラム・ユトレヒト |
cAMPによって直接活性化される交換タンパク質(Epac)の活性をモジュレートするための新規な化合物
|
RS114104A
(en)
|
2002-06-28 |
2007-02-05 |
Idenix (Cayman) Limited, |
2' and 3'-nucleoside prodrugs for treating flaviviridae infections
|
AU2003248748A1
(en)
|
2002-06-28 |
2004-01-19 |
Idenix (Cayman) Limited |
2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
|
DE14169110T1
(de)
|
2002-06-28 |
2022-05-12 |
Centre National De La Recherche Scientifique -Cnrs- |
Modifizierte 2'- und 3'-Nukleosid-Prodrugs zur Behandlung von Flaviridae-Infektionen
|
AU2003259735A1
(en)
|
2002-08-08 |
2004-02-25 |
Sirna Therapeutics, Inc. |
Small-mer compositions and methods of use
|
US7094768B2
(en)
|
2002-09-30 |
2006-08-22 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis C virus infection
|
AU2003274652A1
(en)
|
2002-10-23 |
2004-05-13 |
Obetherapy Biotechnology |
Compounds, compositions and methods for modulating fat metabolism
|
US20040229840A1
(en)
|
2002-10-29 |
2004-11-18 |
Balkrishen Bhat |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
EP2319853B1
(en)
|
2002-12-12 |
2014-03-12 |
IDENIX Pharmaceuticals, Inc. |
Process for the production of 2'-branched nucleosides
|
US7393954B2
(en)
|
2002-12-12 |
2008-07-01 |
Reliable Biopharmaceutical Corporation |
Process for the production of pentostatin aglycone and pentostatin
|
US7002006B2
(en)
|
2003-02-12 |
2006-02-21 |
Isis Pharmaceuticals, Inc. |
Protection of nucleosides
|
WO2005011709A1
(en)
|
2003-02-19 |
2005-02-10 |
Yale University |
Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
|
AU2003225705A1
(en)
|
2003-03-07 |
2004-09-30 |
Ribapharm Inc. |
Cytidine analogs and methods of use
|
EP1613261A4
(en)
|
2003-04-09 |
2011-01-26 |
Novo Nordisk As |
INTRA-CELLULAR FORMATION OF PEPTIDE CONJUGATES
|
US20040259934A1
(en)
|
2003-05-01 |
2004-12-23 |
Olsen David B. |
Inhibiting Coronaviridae viral replication and treating Coronaviridae viral infection with nucleoside compounds
|
EP1656093A2
(en)
|
2003-05-14 |
2006-05-17 |
Idenix (Cayman) Limited |
Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
CA2537114C
(en)
|
2003-08-27 |
2012-10-02 |
Biota, Inc. |
Tricyclic nucleosides or nucleotides as therapeutic agents
|
AU2004274942B2
(en)
|
2003-09-18 |
2008-02-28 |
Isis Pharmaceuticals, Inc. |
Modulation of eIF4E expression
|
AU2004280256A1
(en)
|
2003-10-08 |
2005-04-21 |
Organix, Inc. |
Pyrovalerone analogs and therapeutic uses thereof
|
DE10348044A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
US7144868B2
(en)
|
2003-10-27 |
2006-12-05 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
WO2005044836A2
(de)
|
2003-11-05 |
2005-05-19 |
Genovoxx Gmbh |
Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
|
JP2007517019A
(ja)
|
2003-12-29 |
2007-06-28 |
カン−フィテ・バイオファーマ・リミテッド |
多発性硬化症の治療方法
|
DE102004009704A1
(de)
|
2004-02-27 |
2005-09-15 |
Dmitry Cherkasov |
Makromolekulare Nukleotidverbindungen und Methoden zu deren Anwendung
|
GB0413726D0
(en)
|
2004-06-18 |
2004-07-21 |
Lauras As |
Compounds
|
BRPI0512360A
(pt)
|
2004-06-23 |
2008-03-11 |
Idenix Cayman Ltd |
derivados de 5-aza-7-deazapurina para o tratamento de flaviviridae
|
US7825102B2
(en)
|
2004-07-28 |
2010-11-02 |
Can-Fite Biopharma Ltd. |
Treatment of dry eye conditions
|
PL1778239T3
(pl)
|
2004-07-28 |
2014-01-31 |
Can Fite Biopharma Ltd |
Agoniści receptora adenozynowego A3 do leczenia zaburzeń suchego oka w tym zespołu Sjogrena
|
WO2006050501A2
(en)
|
2004-11-03 |
2006-05-11 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
MX2007005525A
(es)
|
2004-11-08 |
2007-07-05 |
Can Fite Biopharma Ltd |
Tratamiento terapeutico de resorcion ose acelerada.
|
JP2006131596A
(ja)
|
2004-11-09 |
2006-05-25 |
Univ Nagoya |
ヌクレオチド及びその誘導体の製造方法
|
WO2006063149A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Regents Of The University Of Minnesota |
Nucleosides with antiviral and anticancer activity
|
WO2006063717A2
(en)
|
2004-12-16 |
2006-06-22 |
Febit Biotech Gmbh |
Polymerase-independent analysis of the sequence of polynucleotides
|
RS52458B
(en)
|
2005-02-04 |
2013-02-28 |
Millennium Pharmaceuticals Inc. |
E1 ENZYMING ENZYME INHIBITORS
|
US8802840B2
(en)
|
2005-03-08 |
2014-08-12 |
Biota Scientific Management Pty Ltd. |
Bicyclic nucleosides and nucleotides as therapeutic agents
|
US20100279974A1
(en)
|
2005-03-09 |
2010-11-04 |
Claire Pierra |
Nucleosides With Non-Natural Bases as Anti-Viral Agents
|
JP2006248949A
(ja)
|
2005-03-09 |
2006-09-21 |
Univ Nagoya |
ヌクレオシド誘導体、ヌクレオチド誘導体及びそれらの製造方法
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
EP1885876A2
(de)
|
2005-03-17 |
2008-02-13 |
Genovoxx GmbH |
Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
|
US20060229265A1
(en)
|
2005-03-30 |
2006-10-12 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
EP1876894A1
(en)
|
2005-04-26 |
2008-01-16 |
The Board of Trustees of the University of Illinois |
Nucleoside compounds and methods of use thereof
|
WO2007006544A2
(en)
|
2005-07-12 |
2007-01-18 |
Vrije Universiteit Brussel |
Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders
|
WO2007020018A1
(en)
|
2005-08-12 |
2007-02-22 |
Universite Libre De Bruxelles |
Use of purinergic and pyrimidinergic receptor agonists for dendritic cells based immunotherapies
|
CN101287472B
(zh)
|
2005-08-15 |
2011-10-12 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的4'-取代前核苷酸的氨基磷酸酯类化合物
|
US8067391B2
(en)
|
2005-10-03 |
2011-11-29 |
University Health Network |
ODCase inhibitors for the treatment of malaria
|
CA2631129A1
(en)
|
2005-11-09 |
2007-05-18 |
Tosoh Corporation |
Nucleobase having perfluoroalkyl group and process for producing the same
|
EP2010553A1
(en)
|
2006-04-03 |
2009-01-07 |
AstraZeneca AB |
Substituted adenines and the uses thereof
|
WO2007149554A2
(en)
|
2006-06-22 |
2007-12-27 |
The Johns Hopkins University |
Methods for restoring neural function
|
GB0614947D0
(en)
|
2006-07-27 |
2006-09-06 |
Isis Innovation |
Epitope reduction therapy
|
WO2008019124A1
(en)
|
2006-08-08 |
2008-02-14 |
Millennium Pharmaceuticals, Inc. |
Heteroaryl compounds useful as inhibitors of e1 activating enzymes
|
DE102006037786A1
(de)
|
2006-08-11 |
2008-03-20 |
Resprotect Gmbh |
Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung
|
GB0618235D0
(en)
|
2006-09-15 |
2006-10-25 |
Lauras As |
Process
|
WO2008083465A1
(en)
|
2007-01-08 |
2008-07-17 |
University Health Network |
Pyrimidine derivatives as anticancer agents
|
WO2008086042A2
(en)
|
2007-01-10 |
2008-07-17 |
Chisari Francis V |
Preventing infection by a measles or respiratory syncytial virus
|
PT2114980E
(pt)
|
2007-01-12 |
2012-09-25 |
Biocryst Pharm Inc |
Análogos de nucleósidos anti-virais
|
WO2008089439A2
(en)
|
2007-01-18 |
2008-07-24 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
|
WO2008095050A1
(en)
|
2007-01-30 |
2008-08-07 |
Pharmacyclics, Inc. |
Methods for determining cancer resistance to histone deacetylase inhibitors
|
AU2008210411A1
(en)
|
2007-01-31 |
2008-08-07 |
Alios Biopharma, Inc. |
2-5A derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
|
US8324179B2
(en)
|
2007-02-09 |
2012-12-04 |
Gilead Sciences, Inc. |
Nucleoside analogs for antiviral treatment
|
JP2008214305A
(ja)
|
2007-03-07 |
2008-09-18 |
Kotobuki Seiyaku Kk |
置換アミン誘導体及びこれを有効成分とする医薬組成物
|
WO2008117046A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo [4, 3-d] pyrimidines as antibacterial compounds
|
WO2008117047A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolo[3, 4-d]pyrimidine derivatives as antibacterial compounds
|
US7964580B2
(en)
*
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
US20080255038A1
(en)
|
2007-04-11 |
2008-10-16 |
Samuel Earl Hopkins |
Pharmaceutical compositions
|
EP1980568A1
(de)
|
2007-04-13 |
2008-10-15 |
Eberhard Karls Universität Tübingen |
Ethinylierte Heterodinucleosidphosphatanaloga, Verfahren zu deren Herstellung und deren Verwendung
|
PL2014771T3
(pl)
|
2007-06-25 |
2015-05-29 |
Anadys Pharmaceuticals Inc |
Ciągły proces hydrolizy enzymatycznej
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
CN100532388C
(zh)
|
2007-07-16 |
2009-08-26 |
郑州大学 |
2’-氟-4’-取代-核苷类似物、其制备方法及应用
|
EP2019100A1
(en)
|
2007-07-19 |
2009-01-28 |
Santhera Pharmaceuticals (Schweiz) AG |
Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
|
US20090076062A1
(en)
|
2007-09-13 |
2009-03-19 |
Juergen Klaus Maibaum |
Organic Compounds
|
GB0718575D0
(en)
|
2007-09-24 |
2007-10-31 |
Angeletti P Ist Richerche Bio |
Nucleoside derivatives as inhibitors of viral polymerases
|
EP2227234B1
(en)
|
2007-10-15 |
2014-05-07 |
Can-Fite Biopharma Ltd. |
Method for inducing hepatocyte proliferation and uses thereof
|
US20090318380A1
(en)
|
2007-11-20 |
2009-12-24 |
Pharmasset, Inc. |
2',4'-substituted nucleosides as antiviral agents
|
US20090176732A1
(en)
|
2007-12-21 |
2009-07-09 |
Alios Biopharma Inc. |
Protected nucleotide analogs
|
US20090181921A1
(en)
|
2007-12-21 |
2009-07-16 |
Alios Biopharma Inc. |
2-5a analogs and their methods of use
|
ATE551342T1
(de)
|
2008-02-22 |
2012-04-15 |
Irm Llc |
Heterocyclische verbindungen und zusammensetzungen als c-kit- und pdgfr- kinasehemmer
|
JP5485140B2
(ja)
*
|
2008-04-10 |
2014-05-07 |
浜理薬品工業株式会社 |
5−メチルウリジンを出発原料とするエチニルチミジン化合物の製造方法
|
WO2009126293A2
(en)
|
2008-04-11 |
2009-10-15 |
Yale University |
Potent chimeric nrti-nnrti bifunctional inhibitors of hiv-1 reverse transcriptase
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
US20090274686A1
(en)
|
2008-05-02 |
2009-11-05 |
Yat Sun Or |
Nucleoside phosphonate derivatives
|
WO2010036407A2
(en)
|
2008-05-15 |
2010-04-01 |
Biocryst Pharmaceuticals, Inc. |
Antiviral nucleoside analogs
|
US8173621B2
(en)
*
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
DE102008035299A1
(de)
|
2008-07-29 |
2010-02-04 |
Resprotect Gmbh |
Konjugat aus Hsp27 und einem Nukleosid, Verfahren zur Phosphorylierung von Hsp27 und Verwendung zur Herstellung eines Arzneimittels
|
GB0815315D0
(en)
|
2008-08-21 |
2008-09-24 |
Univ Leiden |
Organ protection
|
GB0815968D0
(en)
|
2008-09-03 |
2008-10-08 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
CN102216316A
(zh)
|
2008-09-05 |
2011-10-12 |
寿制药株式会社 |
取代胺衍生物及以其为有效成分的药物组合物
|
WO2010030858A1
(en)
*
|
2008-09-15 |
2010-03-18 |
Enanta Pharmaceuticals, Inc. |
4'-allene-substituted nucleoside derivatives
|
EP3587434A1
(en)
|
2008-09-23 |
2020-01-01 |
Alnylam Pharmaceuticals Inc. |
Chemical modifications of monomers and oligonucleotides with click components for conjugation with ligands
|
CN102264374B
(zh)
|
2008-10-24 |
2015-01-07 |
Isis制药公司 |
5′和2′双取代的核苷和由其制备的低聚化合物
|
EA019295B1
(ru)
|
2008-12-23 |
2014-02-28 |
Джилид Фармассет, Ллс. |
Соединения пуриновых нуклеозидов и способ их получения
|
GB0900914D0
(en)
|
2009-01-20 |
2009-03-04 |
Angeletti P Ist Richerche Bio |
Antiviral agents
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
CA2751458C
(en)
|
2009-02-06 |
2018-06-05 |
Rfs Pharma, Llc |
Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
|
US8975389B2
(en)
*
|
2009-03-02 |
2015-03-10 |
Alnylam Pharmaceuticals, Inc. |
Nucleic acid chemical modifications
|
US20100240604A1
(en)
|
2009-03-20 |
2010-09-23 |
Alios Biopharma, Inc. |
Protected nucleotide analogs
|
BRPI1009324A2
(pt)
|
2009-03-20 |
2015-11-24 |
Alios Biopharma Inc |
compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
|
JP2012526831A
(ja)
|
2009-05-12 |
2012-11-01 |
サザン リサーチ インスティテュート |
2’−フルオロアラビノヌクレオシド及びその使用
|
EP2264169A1
(en)
|
2009-06-15 |
2010-12-22 |
Qiagen GmbH |
Modified siNA
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
WO2011005860A2
(en)
|
2009-07-07 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
5' phosphate mimics
|
TW201111378A
(en)
|
2009-09-11 |
2011-04-01 |
Bayer Schering Pharma Ag |
Substituted (heteroarylmethyl) thiohydantoins
|
WO2011057204A2
(en)
|
2009-11-06 |
2011-05-12 |
The Johns Hopkins University |
Lrrk2-mediated neuronal toxicity
|
US9198972B2
(en)
|
2010-01-28 |
2015-12-01 |
Alnylam Pharmaceuticals, Inc. |
Monomers and oligonucleotides comprising cycloaddition adduct(s)
|
US20130109645A1
(en)
|
2010-03-31 |
2013-05-02 |
The united States of America,as represented by Secretary,Dept.,of Health and Human Services |
Adenosine receptor agonists for the treatment and prevention of vascular or joint capsule calcification disorders
|
WO2011133871A2
(en)
|
2010-04-22 |
2011-10-27 |
Alnylam Pharmaceuticals, Inc. |
5'-end derivatives
|
KR101701510B1
(ko)
|
2010-07-09 |
2017-02-01 |
엘지이노텍 주식회사 |
발광소자
|
KR101995598B1
(ko)
|
2010-07-19 |
2019-07-02 |
길리애드 사이언시즈, 인코포레이티드 |
부분입체 이성질성으로 순수한 포스포라미데이트 전구약물의 제조 방법
|
PL2595980T3
(pl)
|
2010-07-22 |
2015-03-31 |
Gilead Sciences Inc |
Sposoby i związki do leczenia infekcji wirusowych Paramyxoviridae
|
JP5640552B2
(ja)
|
2010-08-23 |
2014-12-17 |
セイコーエプソン株式会社 |
制御装置、表示装置及び表示装置の制御方法
|
US20120070411A1
(en)
|
2010-09-22 |
2012-03-22 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
BR112013005872A2
(pt)
|
2010-09-22 |
2019-09-24 |
Alios Biopharma Inc |
compostos, composição farmacêutica e respectivos usos
|
WO2012040124A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
AR083221A1
(es)
|
2010-09-29 |
2013-02-06 |
Univ Nac Quilmes |
Proceso para producir dialquilfosfotriesteres de nucleosidos mediante transesterificacion enzimatica y desproteccion de los mismos para producir nucleosidos monofosfato
|
CN103391939B
(zh)
|
2010-12-03 |
2016-03-09 |
Epizyme股份有限公司 |
作为表观遗传酶调节剂的经取代的嘌呤和7-氮杂嘌呤化合物
|
EP2655392B1
(en)
|
2010-12-22 |
2018-04-18 |
Alios Biopharma, Inc. |
Cyclic nucleotide analogs
|
CN103403014B
(zh)
|
2011-01-03 |
2016-07-06 |
河南美泰宝生物制药有限公司 |
O-(经取代的苯甲基)氨基磷酸酯化合物及其治疗用途
|
RU2640582C2
(ru)
|
2011-08-01 |
2018-01-10 |
Мбс Фарма, Инк. |
Производные витамина в6 нуклеотидов, ациклических нуклеотидов и ациклических нуклеозидных фосфонатов
|
CN103102345B
(zh)
|
2011-11-14 |
2015-06-03 |
广东东阳光药业有限公司 |
氨基喹唑啉类衍生物及其盐和使用方法
|
AU2013235220C1
(en)
|
2011-12-22 |
2019-03-28 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
AU2012358804B2
(en)
|
2011-12-22 |
2018-04-19 |
Alios Biopharma, Inc. |
Substituted phosphorothioate nucleotide analogs
|
JP6180432B2
(ja)
|
2011-12-22 |
2017-08-16 |
コネクシオス ライフ サイエンシズ プライベート リミテッド |
アザアダマンタン誘導体およびその使用
|
PL2794600T3
(pl)
|
2011-12-22 |
2018-06-29 |
Novartis Ag |
Pochodne 2,3-dihydro-benzo[1,4]oksazyny i powiązane związki jako inhibitory kinazy fosfoinozytydu-3 (PI3K) do leczenia np. reumatoidalnego zapalenia stawów
|
AR089284A1
(es)
|
2011-12-22 |
2014-08-13 |
Galapagos Nv |
Dihidropirimidinoisoquinolinonas y composiciones farmaceuticas de las mismas para el tratamiento de trastornos inflamatorios
|
RU2669695C2
(ru)
|
2011-12-22 |
2018-10-15 |
Конекшис Лайф Сайенсиз Пвт. Лтд. |
Циклические амидные производные как ингибиторы 11-бета-гидроксистероид-дегидрогеназы и их применение
|
CN104114568B
(zh)
|
2011-12-22 |
2017-09-01 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
EP2834258B1
(en)
|
2012-03-13 |
2017-01-04 |
Gilead Sciences, Inc. |
2'- substituted carba-nucleoside analogs for antiviral treatment
|
WO2013138210A1
(en)
|
2012-03-14 |
2013-09-19 |
Ning Xi |
Substituted cyclic compounds and methods of use
|
WO2013142159A1
(en)
|
2012-03-21 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
US8916538B2
(en)
|
2012-03-21 |
2014-12-23 |
Vertex Pharmaceuticals Incorporated |
Solid forms of a thiophosphoramidate nucleotide prodrug
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CN104334570B
(zh)
|
2012-03-21 |
2017-06-06 |
艾丽奥斯生物制药有限公司 |
制备取代的核苷酸类似物的方法
|
EP2827876A4
(en)
|
2012-03-22 |
2015-10-28 |
Alios Biopharma Inc |
PHARMACEUTICAL COMBINATIONS WITH A THIONUCLEOTIDE ANALOG
|
WO2013151975A1
(en)
|
2012-04-02 |
2013-10-10 |
Northeastern University |
Compositions and methods for the inhibition of methyltransferases
|
US9809616B2
(en)
|
2012-10-29 |
2017-11-07 |
Emory University |
Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
|
SG11201407674TA
(en)
|
2012-05-22 |
2014-12-30 |
Idenix Pharmaceuticals Inc |
D-amino acid compounds for liver disease
|
KR20150027155A
(ko)
|
2012-07-03 |
2015-03-11 |
브리스톨-마이어스 스큅 컴퍼니 |
바이러스 감염의 치료를 위한 뉴클레오시드 화합물의 부분입체이성질체적으로 풍부한 포스포르아미데이트 유도체의 제조 방법
|
WO2014022639A1
(en)
|
2012-08-01 |
2014-02-06 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (4-isopropoxy-3-methoxyphenyl)(2'-methyl-6'-(trifluoromethyl)-3',4'-dihydro-2'h-spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]-1-yl)methanone
|
WO2014026198A1
(en)
|
2012-08-10 |
2014-02-13 |
Epizyme, Inc. |
Inhibitors of protein methyltransferase dot1l and methods of use thereof
|
US10294261B2
(en)
|
2012-09-04 |
2019-05-21 |
Kabushiki Kaisha Dnaform |
Compound, nucleic acid, labeling substance, and detection method
|
KR102200628B1
(ko)
|
2012-09-26 |
2021-01-08 |
메르크 파텐트 게엠베하 |
Parp 억제제로서의 퀴나졸리논 유도체
|
CN104640858B
(zh)
|
2012-09-26 |
2018-11-06 |
霍夫曼-拉罗奇有限公司 |
环醚吡唑-4-基-杂环基-甲酰胺化合物及使用方法
|
GB201220843D0
(en)
|
2012-11-20 |
2013-01-02 |
Univ College Cork Nat Univ Ie |
Compound
|
EA201590943A1
(ru)
|
2012-12-21 |
2016-01-29 |
Алиос Биофарма, Инк. |
Замещенные нуклеозиды, нуклеотиды и их аналоги
|
WO2014100498A1
(en)
|
2012-12-21 |
2014-06-26 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
WO2014134251A1
(en)
|
2013-02-28 |
2014-09-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
WO2014164533A1
(en)
|
2013-03-11 |
2014-10-09 |
Vertex Pharmaceuticals Incorporated |
Methods of stereoselective synthesis of substituted nucleoside analogs
|
US9504705B2
(en)
|
2013-04-05 |
2016-11-29 |
Alios Biopharma, Inc. |
Hepatitis C viral infection treatment using a combination of compounds
|
US9815864B2
(en)
|
2013-06-26 |
2017-11-14 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
KR20160023711A
(ko)
|
2013-06-26 |
2016-03-03 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
|
CN113712989A
(zh)
|
2013-10-11 |
2021-11-30 |
艾丽奥斯生物制药有限公司 |
取代的核苷、核苷酸及其类似物
|
NZ727392A
(en)
|
2014-06-24 |
2018-04-27 |
Alios Biopharma Inc |
Methods of preparing substituted nucleotide analogs
|
EP3160475B1
(en)
|
2014-06-24 |
2024-01-03 |
Janssen Pharmaceuticals, Inc. |
Substituted nucleosides and nucleotides to treat filoviridae infections
|
JP6728075B2
(ja)
|
2014-06-24 |
2020-07-22 |
ヤンセン バイオファーマ インク. |
置換ヌクレオシド、ヌクレオチドおよびその類似体
|
JP2017525681A
(ja)
|
2014-07-22 |
2017-09-07 |
アリオス バイオファーマ インク. |
パラミクソウイルスの治療方法
|
EP3177299A4
(en)
|
2014-08-05 |
2018-04-04 |
Alios Biopharma, Inc. |
Combination therapy for treating a paramyxovirus
|
TWI673283B
(zh)
|
2014-08-21 |
2019-10-01 |
美商基利科學股份有限公司 |
2’-氯胺基嘧啶酮及嘧啶二酮核苷類
|
US9981175B2
(en)
|
2014-09-12 |
2018-05-29 |
Dan DeLaRosa |
Taekwondo bag
|
US9908914B2
(en)
|
2014-10-28 |
2018-03-06 |
Alios Biopharma, Inc. |
Methods of preparing substituted nucleoside analogs
|
MA41213A
(fr)
|
2014-12-19 |
2017-10-24 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
MA41441A
(fr)
|
2014-12-19 |
2017-12-12 |
Alios Biopharma Inc |
Nucléosides substitués, nucléotides et analogues de ceux-ci
|
CN109890831A
(zh)
|
2016-08-12 |
2019-06-14 |
詹森生物制药有限公司 |
被取代的核苷、核苷酸以及它们的类似物
|
US20180117042A1
(en)
|
2016-10-27 |
2018-05-03 |
Alios Biopharma, Inc. |
Methods for treating respiratory syncytial virus infection
|